U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H15NO4.ClH
Molecular Weight 309.745
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ZELANDOPAM HYDROCHLORIDE

SMILES

Cl.OC1=CC=C(C=C1O)[C@@H]2CNCC3=C2C=CC(O)=C3O

InChI

InChIKey=NHCWZEQEFHNLBQ-PPHPATTJSA-N
InChI=1S/C15H15NO4.ClH/c17-12-3-1-8(5-14(12)19)10-6-16-7-11-9(10)2-4-13(18)15(11)20;/h1-5,10,16-20H,6-7H2;1H/t10-;/m0./s1

HIDE SMILES / InChI

Molecular Formula C15H15NO4
Molecular Weight 273.2839
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: https://www.ncbi.nlm.nih.gov/pubmed/9809482 | https://www.pharmacodia.com/yaodu/html/v1/chemicals/9885db9d9ee078055567f91ba45eabde.html | http://adisinsight.springer.com/drugs/800002584

YM-435 is a dopamine D1 agonist. The renal and cardiovascular effects of YM-435 may be suitable for the treatment of patients with renal insufficiency, heart failure and hypertension. It has been in phase II clinical trials for the treatment of heart failure and hypertension. YM435 may be useful in the preservation of renal function in ischemia-induced acute renal failure. Also, it might be a useful as therapeutic agent for the treatment of congestive heart failure.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: 489110.0
Gene Symbol: DRD1
2.9 nM [Ki]
Conditions
PubMed

PubMed

TitleDatePubMed
Effect of zelandopam, a dopamine D1-like receptor agonist, in puromycin aminonucleoside nephrosis rats.
2005 Mar 7
Patents

Sample Use Guides

Dog: 0.1-3 ug/kg/min
Route of Administration: Intravenous
In Vitro Use Guide
YM-435 displayed a capacity to promote cAMP formation in bovine retina when ATP/GppNHp was present. The maximally stimulated level of CAMP induced by YM 435 (210% of the controls; ATP/GppNHp only, no agonist added), was attained with 10 uM agonist. The EC50 value of YM-435-induced cAMP formation was 1.97 uM.
Substance Class Chemical
Created
by admin
on Sat Dec 16 05:30:56 GMT 2023
Edited
by admin
on Sat Dec 16 05:30:56 GMT 2023
Record UNII
99I770UEI4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ZELANDOPAM HYDROCHLORIDE
WHO-DD  
Common Name English
OHM-11252
Code English
YM-435
Code English
7,8-ISOQUINOLINEDIOL, 4-(3,4-DIHYDROXYPHENYL)-1,2,3,4-TETRAHYDRO-, HYDROCHLORIDE (1:1), (4S)-
Systematic Name English
7,8-ISOQUINOLINEDIOL, 4-(3,4-DIHYDROXYPHENYL)-1,2,3,4-TETRAHYDRO-, HYDROCHLORIDE, (S)-
Systematic Name English
SELANDOPAM HYDROCHLORIDE
Common Name English
Zelandopam hydrochloride [WHO-DD]
Common Name English
7,8-ISOQUINOLINEDIOL, 4-(3,4-DIHYDROXYPHENYL)-1,2,3,4-TETRAHYDRO-, HYDROCHLORIDE, (4S)-
Systematic Name English
Code System Code Type Description
PUBCHEM
3078104
Created by admin on Sat Dec 16 05:30:56 GMT 2023 , Edited by admin on Sat Dec 16 05:30:56 GMT 2023
PRIMARY
FDA UNII
99I770UEI4
Created by admin on Sat Dec 16 05:30:56 GMT 2023 , Edited by admin on Sat Dec 16 05:30:56 GMT 2023
PRIMARY
EPA CompTox
DTXSID50929974
Created by admin on Sat Dec 16 05:30:56 GMT 2023 , Edited by admin on Sat Dec 16 05:30:56 GMT 2023
PRIMARY
CAS
138086-00-7
Created by admin on Sat Dec 16 05:30:56 GMT 2023 , Edited by admin on Sat Dec 16 05:30:56 GMT 2023
PRIMARY
Related Record Type Details
SOLVATE->ANHYDROUS
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY